Pfizer (PFE) FCF Payout Ratio (2009 - 2026)

Pfizer (PFE) has 18 years of FCF Payout Ratio data on file, last reported at 1.12 in Q1 2026.

• FCF Payout Ratio for Q1 2026 came in at 1.12, down 18.46% year-over-year; the trailing twelve-month figure through Mar 2026 was 1.03 (down 75.63% YoY), and the FY2025 annual result was 1.08, up 11.33% from the prior year.
• FCF Payout Ratio improved to 1.12 in Q1 2026 per PFE's latest filing, from 0.54 in the prior quarter.
• Over five years, FCF Payout Ratio peaked at 31.55 in Q2 2023 and troughed at 2.04 in Q2 2025.
• A 5-year average of 2.77 and a median of 0.55 in 2023 frame the typical range for FCF Payout Ratio.
• On a YoY basis, FCF Payout Ratio climbed as much as 8173.45% in 2023 and fell as far as 460.69% in 2023.
• A 5-year view of FCF Payout Ratio shows it stood at 0.37 in 2022, then soared by 51.07% to 0.55 in 2023, then jumped by 220.69% to 1.77 in 2024, then tumbled by 69.31% to 0.54 in 2025, then surged by 106.65% to 1.12 in 2026.
• Business Quant data shows PFE's FCF Payout Ratio at 1.12 in Q1 2026, 0.54 in Q4 2025, and 0.61 in Q3 2025.